|
1
|
Mortensen PB: The incidence of cancer in
schizophrenic patients. J Epidemiol Commun Health. 43:43–47. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lawrence D, Holman CD, Jablenski AV,
Threlfall TJ and Fuller SA: Excess cancer mortality in Western
Australian psychiatric patients due to higher case fatality rates.
Acta Psychiatr Scand. 101:382–388. 2000. View Article : Google Scholar
|
|
3
|
Barak Y, Achiron A, Mandel M, Mirecki I
and Aizenberg D: Reduced cancer incidence among patients with
schizophrenia. Cancer. 104:2817–2821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leucht S, Bunkard T, Henderson J, Maj M
and Sartorius N: Physical illness and schizophrenia: a review of
the literature. Acta Psychiatr Scand. 116:317–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chou FHC, Tsai KY, Su CY and Lee CC: The
incidence and relative risk factors for developing cancer among
patients with schizophrenia: a nine-year follow-up study. Schizophr
Res. 129:97–103. 2011.PubMed/NCBI
|
|
6
|
Lin GM, Chen YJ, Kuo DJ, Jaiteh LES, Wu
YC, Lo TS and Li YH: Cancer incidence in patients with
schizophrenia or bipolar disorder: a nationwide population-based
study in Taiwan, 1997–2009. Schizophr Bull. 1:1–10. 2011.
|
|
7
|
Fanous AH and Kendler KS: Genetic
heterogeneity, modifier genes, and quantitative phenotypses in
psychiatric illness: searching for a framework. Mol Psychiatry.
10:6–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar
|
|
9
|
Rybakowski JK, Skibinska M, Kapelski P,
Kaczmarek L and Hauser J: Functional polymorphism of the matrix
metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res.
109:90–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Catts VS and Catts SV: Apoptosis and
schizophrenia: is the tumour suppressor gene, p53, a candidate
susceptibility gene? Schizophr Res. 41:405–415. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L,
Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and
down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in
chronic lymphocytic leukaemia. Proc Natl Acad Sci USA.
99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
Mitsudomi T and Takahashi T: Reduced expression of the let-7
microRNAs in human lung cancers in association with shortened
postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hansen T, Olsen L, Lindow M, Jakobsen K,
Ullum H, Jonsson E, Adreassen O, Djurovic S, Melle I, Agartz I,
Hall H, Timm S, Wang AG and Werge T: Brain expressed microRNAs
implicated in schizophrenia etiology. Plos One. 9:1–7. 2007.
|
|
15
|
Beveridge NJ, Tooney PA, Carroll AP,
Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I and Cairns MJ:
Dysregulation of miRNA 181b in the temporal cortex in
schizophrenia. Human Mol Genet. 17:1156–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
First MB, Spitzer RL, Gibbon M and William
JBM: Structured Clinical Interview for DSM-IV Axis I Disorders
Patient edition. New York State Psychiatric Institute, Biometrics
Research; New York: 1997
|
|
17
|
Kay SR, Opler LA and Lindenmayer JP: The
Positive and Negative Syndrome Scale (PANSS): rational and
standardization. Br J Psychiatry. 155(Suppl): 59–65. 1987.
|
|
18
|
Cui DH, Jiang KD, Jiang SD, Xu YF and Yao
H: The tumor suppressor adenomatous polyposis coli gene is
associated with susceptibility to schizophrenia. Mol Psychiatry.
10:669–677. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lichtermann D, Ekelund J, Pukkala E,
Tanskanen A and Lonnqvist J: Incidence of cancer among persons with
schizophrenia and their relatives. Arch Gen Psychiatry. 58:573–578.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dalton SO, Johansen C, Poulsen AH,
Norgaard M, Sorensen HT, McLaughlin JK, Mortensen PB and Friis S:
Cancer risk among users of neuroleptic medication: a
population-based cohort study. Br J Cancer. 95:934–939. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao X, Yeo G, Muotri AR, Kuvabara T and
Gage FH: Noncoding RNAs in the mammalian central nervous system. An
Rev Neurosci. 29:77–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennel DA and Vasconcelos MH: MicroRNA regulation of core apoptosis
pathways in cancer. Eur J Cancer. 47:163–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho WC: MicroRNAs in cancer - from
research to therapy. Biochim Biophys Acta. 1805:209–217.
2010.PubMed/NCBI
|
|
24
|
Fu LI, Wen X, Bao JK and Liu B:
MicroRNA-modulated autophagic signaling networks in cancer. Int J
Biochem Cell Biol. 44:733–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim A, Reimers M, Maher B, Williamson V,
McMichael O, McClay J, van den Oord E, Riley B, Kendler K and
Vladimirov V: MicroRNA expression profiling in the prefrontal
cortex of individuals affected with schizophrenia and bipolar
disorders. Schizophr Res. 124:183–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li ZY, Yang Y, Ming M and Liu B:
Mitochondrial ROS generation for regulation of autophagic pathways
in cancer. Biochem Biophys Res Commun. 414:5–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jian X, Xiao-yan Z, Bin H, Yu-feng Z, Bo
K, Zhi-nong W and Xin N: Mir-204 regulate cardiomyocyte autophagy
induced by hypoxia-reoxygenetion through LC3-II. Int J Cardiol.
148:111–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abraham D, Jackson N, Gundara JS, Zhao J,
Gill AJ, Delbridge L, Robinson BG and Sidhu SB: MicroRNA profiling
of sporadic and hereditary medullary thyroid cancer identifies
predictors of nodal metastasis, prognosis, and potential
therapeutic targets. Clin Cancer Res. 17:4772–4781. 2011.
View Article : Google Scholar
|
|
29
|
Wang G, Mao W and Zheng S: MicroRNA-183
regulates Ezrin expression in lung cancer cells. FEBS Lett.
582:3663–3668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sarver A, Li L and Subramanian S: MicroRNA
miR-183 functions as an oncogene by targeting the transcriptional
factor ERG1 and promoting tymor cell migration. Cancer Res.
70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang
X and Wang L: Down-regulation of miR-183 promotes migration and
invasion of osteosarcoma by targeting Ezrin. Am J Pathol.
180:2440–2451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Liang S, Jin H, Xu C, Ma D and Lu X:
Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is
involved in migration, invasion and viability of ovarian cancer
cells. Oncol Rep. 27:1835–1842. 2012.PubMed/NCBI
|
|
34
|
Hermeking H: P53 enters the microRNA
world. Cancer Cell. 12:414–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). JBC.
282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Frankel LB, Christoffersen NR, Jakobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perkins DO, Jeffries CD, Jarskog LF,
Thomson JM, Woods K, Newman MA, Parker JS, Jim JP and Hammond SM:
MicroRNA expression in the prefrontal cortex of individuals with
schizophrenia and schizoaffective disorder. Genome Biol. 8:R272007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Abu-Elneel K, Liu T, Gazzaniga FS,
Nishimura Y, Wall DP, Geschwind DH, Lao K and Kosik KS:
Heterogenous dysregulation of microRNAs across the autism spectrum.
Neurogenetics. 9:153–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Junn E, Lee KW, Jeong BS, Chan TW, Imb J
and Mouradian MM: Repression of alpha-synuclein expression and
toxicity by microRNA-7. Proc Natl Acad Sci USA. 106:13052–13057.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cogswell JP, Ward J, Taylor A, Waters M,
Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha
RK, Richardson JC, Saunders AM, Roses AD and Richards CA:
Identification of miRNA changes in Alzheimer’s disease brain and
CSF yields putative biomarkers and insights into disease pathways.
J Alzheimer Dis. 14:27–41. 2008.
|
